BridgeBio Pharma, Inc.
BBIO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$543 | -$643 | -$485 | -$586 |
| Dep. & Amort. | $6 | $6 | $7 | $6 |
| Deferred Tax | $0 | $0 | $0 | -$31 |
| Stock-Based Comp. | $96 | $0 | $92 | $100 |
| Change in WC | $32 | $5 | $28 | -$4 |
| Other Non-Cash | -$111 | $104 | -$61 | $18 |
| Operating Cash Flow | -$521 | -$528 | -$419 | -$498 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$1 | -$5 | -$48 |
| Net Acquisitions | -$0 | $0 | $0 | -$35 |
| Inv. Purchases | -$88 | -$137 | -$193 | -$643 |
| Inv. Sales/Matur. | $158 | $193 | $533 | $477 |
| Other Inv. Act. | -$8 | -$1 | $119 | $49 |
| Investing Cash Flow | $61 | $54 | $453 | -$201 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $477 | $0 | -$20 | $1,080 |
| Stock Issued | $315 | $450 | $5 | $0 |
| Stock Repurch. | -$8 | -$7 | -$2 | -$205 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$35 | $9 | $4 | -$138 |
| Financing Cash Flow | $748 | $452 | -$13 | $736 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $289 | -$22 | $21 | $38 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $395 | $417 | $396 | $359 |
| End Cash | $683 | $395 | $417 | $396 |
| Free Cash Flow | -$522 | -$529 | -$426 | -$546 |